Influence of methylcobalamin on the vitamin B12 level and manifestations of neuropathy in patients with type 2 diabetes mellitus and metformin-associated vitamin B12 deficiency

Abstract

Background. Adverse side effect of metformin is disturbance in vitamin B12 metabolism associated with low serum vitamin B12 level. B12 hypovitaminosis is accompanied by peripheral neuropathy. The aim of the study was to determine the effectiveness of methylcobalamin (Diacobal preparation manufactured by Kusum Pharm LLC, Ukraine) in correcting vitamin B12 deficiency in diabetic patients with metformin-associated vitamin B12 deficiency, and to establish its effect on manifestations of diabetic neuropathy. Materials and methods. Thirty patients with type 2 diabetes mellitus and metformin-associated vitamin B12 deficiency (< 190 pg/ml) were examined. Duration of metformin administration was 6.1 years on average, the average dose was 2100 mg/day. Methylcobalamin was administered at a dose of 500 mg three times a day for three months. Determination of vitamin B12 content and assessment of neuropathy manifestations was carried out before and after the course of treatment. Results. After the course of treatment, it was found that the average content of vitamin B12 in the blood serum reached the reference values (312.4 ± 39.8 pg/ml). The positive effect of therapy on the severity of clinical manifestations of peripheral sensory motor neuropathy in the examined patients was revealed: in 17 (56.7 %) patients, the severity of numbness in feet significantly decreased, in 6 (20 %) persons, there was a complete disappearance of numbness. The intensity of the pain syndrome decreased in 19 (63.3 %) patients, the pain syndrome was completely removed in 3 (10 %) persons. Conclusions. The relationship between metformin and B12 hypovitaminosis has been confirmed. Diacobal is an effective and safe drug for the prevention and treatment of metformin-induced vitamin B12 deficiency and diabetic neuropathy.

Authors and Affiliations

V. I. Pankiv

Keywords

Related Articles

Combination Therapy «Metformin + Glimepiride» in Patients with Type 2 Diabetes Mellitus (Molecular Mechanisms for Optimization of the Rehabilitation Effect)

This review describes the molecular mechanisms of therapeutic action of the combination of oral antidiabetic drugs «metformin + glimepiride», aimed at the correction of both defects, which determine the development of me...

Monitoring the status of the blood circulation in the lower extremities in patients with diabetes mellitus

Background. Diabetes mellitus (DM) is a current medical and social problem. According to the data from International Diabetes Federation, 415 million people worldwide suffer from DM, and bу 2030, the number of patients i...

Benfotiamine and Alpha-Lipoic Acid in the Treatment of Diabetic Cardiovascular Autonomic Neuropathy (Review of Literature and Own Researches)

The analysis of current views on the mechanisms of fat-soluble form of vitamin B1 (benfotiamine) and α-lipoic acid action, in particular features of their impact on carbohydrate and lipid metabolism, endothelial function...

Morphological Changes of Pulmonary Bloodstream in Type 2 Diabetic Patients

The pathomorphological investigation of pulmonary vessels found the changes being developed in diabetic microangiopathy in other organs and affecting firstly the morphological structures responsive for respiratory exchan...

Current Trends in Pathogenesis, Diagnosis and Prognosis of Inactive Pituitary Adenomas

The paper presents an analysis of data from 138 sources in recent years. The study of factors of the development of inactive pituitary adenomas remains one of the most urgent problems of modern medicine. The development...

Download PDF file
  • EP ID EP630812
  • DOI 10.22141/2224-0721.15.4.2019.174818
  • Views 53
  • Downloads 0

How To Cite

V. I. Pankiv (2019). Influence of methylcobalamin on the vitamin B12 level and manifestations of neuropathy in patients with type 2 diabetes mellitus and metformin-associated vitamin B12 deficiency. Міжнародний ендокринологічний журнал, 15(4), 317-321. https://europub.co.uk./articles/-A-630812